Plain-English translation of NCT07230470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares two different robotic devices designed to help you relearn how to walk after a stroke. One device is called the LoKomat®, an exoskeleton (a wearable robot) that supports your legs while you walk. The other is the C-Mill®, a special treadmill that provides real-time visual feedback as you move. Researchers want to see which one helps you walk better and feel better overall.
After a stroke, many people struggle to walk normally, which affects their independence and quality of life. While robotic devices have shown promise in helping stroke patients regain walking ability, doctors aren't sure which device works best or how much these improvements affect your day-to-day well-being.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to use either the LoKomat® exoskeleton or the C-Mill® treadmill for your therapy sessions. You'll visit the clinic regularly over 12 weeks and have your walking ability, balance, and quality of life assessed at the start, and then again at 4 weeks, 8 weeks, and 12 weeks. The study will measure how much your walking improves and how you feel about your recovery.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Spain